1. Oral flecainide acetate for the treatment of ventricular arrhythmias;HAMERSVELD, D.D.; JOHNSON, T.A.; CONARD, G.J.; CHANG, S.F.; KVAM, D.C.; PITT, B.;New England Journal of Medicine,1981
2. Verapamil in atrial fibrillation and atrial flutter;ARONOW, W.S.; LANDA, D.; PLASENCIA, G.; WONG, R.; KARLSBERG, R.P.; FERLINZ, J.;Clinical Pharmacology and Therapeutics,1979
3. Application of drug metabolism to drug toxicity studies. Annals ofNew York Academy ofSciences;BURNS, J.J.; CUCINELL, S.A.; KOSTER, R.; CONNEY, A.H.;Hospital Update; Antiarrhythmic drugs (2,1965
4. Mexiletine (Ko 1173) in the management of ventricular dysrhythmias;CAMPBELL, N.P.S.; CHATURVEDI, N.C.; KELLY, J.G.; STRONG, J.E.; SHANKS, R.G.; PANTRIDGE, J.F.;Lancet,1973
5. Drugs and genes: therapeutic implications;CHAPMAN, C.J.;Drugs,1977